Evidence map›Paper›PMID 32750099›Full record

ArticlePloS one2020

Fragile neutrophils in surgical patients: A phenomenon associated with critical illness.

Lillian Hesselink, Roy Spijkerman, Pien Hellebrekers, Robert J van Bourgondiën, Enja Blasse, Saskia Haitjema, Albert Huisman, Wouter W van Solinge, Karlijn J P Van Wessem, Leo Koenderman and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Lillian HesselinkDepartment of trauma surgery, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID 0000-0001-8793-6650
Roy SpijkermanDepartment of trauma surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
Pien HellebrekersDepartment of trauma surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
Robert J van BourgondiënDepartment of trauma surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
Enja BlasseDepartment of Clinical Chemistry and Hematology, Utrecht, the Netherlands.
Saskia HaitjemaDepartment of Clinical Chemistry and Hematology, Utrecht, the Netherlands.
Albert HuismanDepartment of Clinical Chemistry and Hematology, Utrecht, the Netherlands.
Wouter W van SolingeDepartment of Clinical Chemistry and Hematology, Utrecht, the Netherlands.
Karlijn J P Van WessemDepartment of trauma surgery, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID 0000-0002-1166-0990
Leo KoendermanCenter for Translational Immunology, Wilhelmina Children's Hospital, Utrecht, the Netherlands.
Luke P H LeenenDepartment of trauma surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
Falco HietbrinkDepartment of trauma surgery, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID 0000-0003-1462-6840
University Medical Center Utrecht · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukocyte viability (determined by e.g. propidium iodide [PI] staining) is automatically measured by hematology analyzers to check for delayed bench time. Incidental findings in fresh blood samples revealed the existence of leukocytes with decreased viability in critically ill surgical patients. Not much is known about these cells and their functional and/or clinical implications. Therefore, we investigated the incidence of decreased leukocyte viability, the implications for leukocyte functioning and its relation with clinical outcomes. An automated alarm was set in a routine hematology analyzer (Cell-Dyn Sapphire) for the presence of non-viable leukocytes characterized by increased fluorescence in the PI-channel (FL3:630±30nm). Patients with non-viable leukocytes were prospectively included and blood samples were drawn to investigate leukocyte viability in detail and to investigate leukocyte functioning (phagocytosis and responsiveness to a bacterial stimulus). Then, a retrospective analysis was conducted to investigate the incidence of fragile neutrophils in the circulation and clinical outcomes of surgical patients with fragile neutrophils hospitalized between 2013-2017. A high FL3 signal was either caused by 1) neutrophil autofluorescence which was considered false positive, or by 2) actual non-viable PI-positive neutrophils in the blood sample. These two causes could be distinguished using automatically generated data from the hematology analyzer. The non-viable (PI-positive) neutrophils proved to be viable (PI-negative) in non-lysed blood samples, and were therefore referred to as 'fragile neutrophils'. Overall leukocyte functioning was not impaired in patients with fragile neutrophils. Of the 11 872 retrospectively included surgical patients, 75 (0.63%) were identified to have fragile neutrophils during hospitalization. Of all patients with fragile neutrophils, 75.7% developed an infection, 70.3% were admitted to the ICU and 31.3% died during hospitalization. In conclusion, fragile neutrophils occur in the circulation of critically ill surgical patients. These cells can be automatically detected during routine blood analyses and are an indicator of critical illness.

Indexed as

Critical IllnessSurgical Procedures, OperativeAgedCell SurvivalFemaleHumansLeukocyte CountMaleMiddle AgedNeutrophils

Identifiers

PMID32750099
PMCPMC7402494
OpenAlexW3047251556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.